October 13, 2022
Via: Drugs.comPeople with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday. The Adderall and Adderall IR shortage is due to intermittent manufacturing delays at […]
July 15, 2022
Via: PharmaphorumThe PureTech group company – which scored the first FDA and EMA approvals for a DTx for attention-deficit hyperactivity disorder (ADHD) – is developing AKL-T01 to tackle cognitive impairments that can affect people with SLE. Cognitive dysfunction occurs in between […]
March 30, 2023
March 28, 2023
March 23, 2023
March 16, 2023